【摘要】 目的观察舒丽启能治疗肠易激综合征患者的疗效。方法将257例患者列为观察对象,对比分析治疗前后患者的症状评分,计算各种症状的改善率。结果各种症状的改善率分别为:腹痛89.34%、腹胀85.59%、腹泻93.18%、便秘81.90%。结论舒丽启能治疗肠易激综合征安全有效。更多还原

【Abstract】 Objective To investigate the curative effect of Cerekinon on the patients with irritable bowel syndrome(IBS).Methods The effects were evaluated by symptom improvement rates before and after treatment for 257 patients with IBS.Results The rates of symptom improvement were 89.34% for abdominal pain,85.59% for flatulence,93.18% for diarrhea,and 81.90% for constipation.Conclusion Cerekinon is effective and safe for the treatment of IBS.更多还原